Drawing on leading practitioner and academic insights, the following webinars are designed to inform and support the treatment and care of patients with chronic myeloid leukaemia (CML).Show more

Rate this content: 
No votes yet
UK | February 2022 | 188508

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com